DUBLIN--(BUSINESS WIRE)--The "Latvia:CBD and Cannabis Regulations" report has been added to ResearchAndMarkets.com's offering.
This report provides a detailed overview of Latvia's regulatory framework for CBD and cannabis, as well as other minor cannabinoids, covering all policy areas from cultivation and extracts to finished products and import/export.
Cannabis is listed as a narcotic under Schedule I of the Law on Procedures for Legal Trade in Narcotic and Psychotropic Substances and Medicines (Narcotics Act).
This includes cannabis resin, oil, extracts and tinctures of cannabis as well as leaves. The list of controlled substances is included in Law on the procedure for entry into force and application of the Criminal Code.
This regulatory report will provide you with:
- A clear and detailed understanding of current regulatory requirements affecting this sector in a specific jurisdiction, enabling you to be confident your business and your products are compliant.
- The ability to plan ahead for specific regulatory changes.
- Strategic understanding of the policy climate within the jurisdiction, enabling you to forecast how it might affect business development.
- Sources of further information, for example, links to full texts of legislation and contact details for relevant government offices.
Key Topics Covered:
- Executive summary
- Outlook
- Hemp plant
- Extracts and synthetics
- Finished products containing CBD and extracts
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
For more information about this report visit https://www.researchandmarkets.com/r/y2qqkn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
